ARCHIVES

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

Adamson Objects to IOM “Primrose Path of Centralization” In Report

March 3, 1989

Natural Substance Blocks Androgen Activity In Vitro

April 27, 2001

FDA’s New Guideline Proposal Meets More NCI Objections

March 19, 1976

Upton Considers Moving Basic Research Contracts To grants; Staff Changes Possible, Newell Stay

July 22, 1977

In Brief: George Santos Wins Bristol-Meyers Award; SG Elects William Creasman President; Levin To MDA

April 1, 1988

Mouse Strains Now Available From NCI

March 18, 1983